<DOC>
	<DOCNO>NCT02044406</DOCNO>
	<brief_summary>To investigate safety , tolerability , pharmacokinetics ( include dose proportionality assessment ) , pharmacodynamics single rise oral dos BI 1181181 ( Single rise dose ( SRD ) part ) Secondly , investigate relative bioavailability tablet versus powder oral solution ( PfOS ) effect food pharmacokinetics BI 1181181 ( Bioavailability/Food effect ( BA/FE ) part )</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Single Rising Oral Doses BI 1181181 Healthy Male Volunteers , Including Investigation Effect Food Bioavailability BI 1181181</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Healthy male accord investigator 's assessment , base follow criterion : complete medical history include physical examination , vital sign blood pressure ( BP ) , pulse rate ( PR ) , 12lead ECG , clinical laboratory test Age 18 50 year ( incl . ) Body mass index ( BMI ) 18.5 29.9 kg/m2 ( incl . ) Signed date write informed consent prior admission study accordance GCP local legislation Exclusion criterion : Any find medical examination ( include BP , PR ECG ) deviate normal judge clinically relevant investigator Repeated measurement systolic blood pressure &lt; 90 mmHg &gt; = 140 mmHg screening Repeated measurement diastolic blood pressure &lt; 55 &gt; = 90 mmHg screening Repeated measurement pulse rate &lt; 50 bpm &gt; 90 bpm screen Any laboratory value outside reference range investigator considers clinical relevance Any evidence concomitant disease judge clinically relevant investigator Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>